We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |


JAMA. 1937;109(21):1724-1725. doi:10.1001/jama.1937.92780470007014.
Text Size: A A A
Published online


The report on the Elixir of Sulfanilamide-Massengill episode published in the November 6 issue of The Journal, pages 1531-1539, contained a survey map of the deaths to October 29. Herewith the survey map is brought down to date. This shows that there have been seventy-three deaths reported to November 11. As may be seen, all but a few of the reported deaths have been from the Southern states. It is emphasized that the additional deaths reported are not recent but have only recently been reported as having followed the administration of Elixir of Sulfanilamide-Massengill. That no recent deaths have occurred shows the effect of the wide publicity initiated by The Journal and the excellent work of the government in removing the product from the market.

In reports appearing in the newspapers and elsewhere there has been considerable confusion; many of the deaths have been attributed to sulfanilamide, which was not the causative factor. As pointed out previously, the diethylene glycol used in the solvent was the harmful agent. There has been further confusion between the various sulfanilamide derivatives, their properties and names, and the chemical difference between ethylene glycol and diethylene glycol. For the information of physicians there is reproduced herewith a chart, modified from that shown at the last annual session of the American Medical


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.